Elizebeth C. Turner

576 total citations
14 papers, 391 citations indexed

About

Elizebeth C. Turner is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Elizebeth C. Turner has authored 14 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Elizebeth C. Turner's work include Inflammatory mediators and NSAID effects (4 papers), Cell Adhesion Molecules Research (3 papers) and Platelet Disorders and Treatments (2 papers). Elizebeth C. Turner is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Cell Adhesion Molecules Research (3 papers) and Platelet Disorders and Treatments (2 papers). Elizebeth C. Turner collaborates with scholars based in Ireland, Sweden and United Kingdom. Elizebeth C. Turner's co-authors include Noel M. Caplice, Charles J. Dorman, B. Therese Kinsella, Arun Kumar, Kenneth Martin, Anne‐Laure Leblond, Chien‐Ling Huang, Tara C. Browne, Kerstin Klinkert and Helen M. Reid and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Molecular Biology.

In The Last Decade

Elizebeth C. Turner

14 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizebeth C. Turner Ireland 12 202 118 82 77 52 14 391
Céline Gracia France 10 242 1.2× 91 0.8× 33 0.4× 9 0.1× 40 0.8× 14 388
Zhuang Li China 13 260 1.3× 45 0.4× 52 0.6× 24 0.3× 31 0.6× 36 517
Nora Tenis Australia 10 352 1.7× 56 0.5× 39 0.5× 73 0.9× 16 0.3× 12 433
Faiza Noreen Switzerland 9 147 0.7× 59 0.5× 38 0.5× 6 0.1× 25 0.5× 15 275
Svetlana M. Dolgilevich United States 11 216 1.1× 25 0.2× 27 0.3× 32 0.4× 20 0.4× 13 349
Christine Göbel Germany 8 393 1.9× 41 0.3× 76 0.9× 11 0.1× 27 0.5× 9 765
Nadine Schuerer Austria 8 96 0.5× 18 0.2× 65 0.8× 20 0.3× 38 0.7× 14 479
Radia Forteza United States 8 148 0.7× 24 0.2× 164 2.0× 10 0.1× 45 0.9× 12 404
Dong Leng China 12 241 1.2× 46 0.4× 28 0.3× 13 0.2× 36 0.7× 27 422
Lucy E. Dalton United Kingdom 10 261 1.3× 23 0.2× 53 0.6× 5 0.1× 47 0.9× 11 435

Countries citing papers authored by Elizebeth C. Turner

Since Specialization
Citations

This map shows the geographic impact of Elizebeth C. Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizebeth C. Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizebeth C. Turner more than expected).

Fields of papers citing papers by Elizebeth C. Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizebeth C. Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizebeth C. Turner. The network helps show where Elizebeth C. Turner may publish in the future.

Co-authorship network of co-authors of Elizebeth C. Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Elizebeth C. Turner. A scholar is included among the top collaborators of Elizebeth C. Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizebeth C. Turner. Elizebeth C. Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Leblond, Anne‐Laure, Kerstin Klinkert, Kenneth Martin, et al.. (2015). Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction. PLoS ONE. 10(9). e0137515–e0137515. 88 indexed citations
2.
Martin, Kenneth, Arun Kumar, Stefan Pierrou, et al.. (2015). A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation. Biomaterials. 69. 22–29. 20 indexed citations
3.
Huang, Chien‐Ling, Anne‐Laure Leblond, Elizebeth C. Turner, et al.. (2015). Synthetic Chemically Modified mRNA-Based Delivery of Cytoprotective Factor Promotes Early Cardiomyocyte Survival Post-Acute Myocardial Infarction. Molecular Pharmaceutics. 12(3). 991–996. 52 indexed citations
4.
Kumar, Arun, Kenneth Martin, Elizebeth C. Turner, et al.. (2013). Role of CX3CR1 Receptor in Monocyte/Macrophage Driven Neovascularization. PLoS ONE. 8(2). e57230–e57230. 33 indexed citations
5.
Turner, Elizebeth C., et al.. (2013). Identification of a Klf4-dependent upstream repressor region mediating transcriptional regulation of the myocardin gene in human smooth muscle cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1829(11). 1191–1201. 30 indexed citations
6.
Reid, Helen M., et al.. (2012). Interaction of the human prostacyclin receptor and the NHERF4 family member intestinal and kidney enriched PDZ protein (IKEPP). Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(10). 1998–2012. 4 indexed citations
7.
Turner, Elizebeth C., et al.. (2012). Regulation of the human prostacyclin receptor gene in megakaryocytes: Major roles for C/EBPδ and PU.1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1819(5). 428–445. 6 indexed citations
8.
Turner, Elizebeth C., et al.. (2011). Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis. Molecular Biology of the Cell. 22(15). 2664–2679. 24 indexed citations
9.
Turner, Elizebeth C. & B. Therese Kinsella. (2010). Estrogen Increases Expression of the Human Prostacyclin Receptor within the Vasculature through an ERα-Dependent Mechanism. Journal of Molecular Biology. 396(3). 473–486. 19 indexed citations
10.
Turner, Elizebeth C., et al.. (2009). Regulated Expression of the α Isoform of the Human Thromboxane A2 Receptor during Megakaryocyte Differentiation: A Coordinated Role for WT1, Egr1, and Sp1. Journal of Molecular Biology. 394(1). 29–45. 14 indexed citations
11.
Turner, Elizebeth C. & B. Therese Kinsella. (2008). Transcriptional Regulation of the Human Prostacyclin Receptor Gene Is Dependent on Sp1, PU.1 and Oct-1 in Megakaryocytes and Endothelial Cells. Journal of Molecular Biology. 386(3). 579–597. 13 indexed citations
12.
McCusker, Matthew P., Elizebeth C. Turner, & Charles J. Dorman. (2007). DNA sequence heterogeneity in Fim tyrosine‐integrase recombinase‐binding elements and functional motif asymmetries determine the directionality of the fim genetic switch in Escherichia coli K‐12. Molecular Microbiology. 67(1). 171–187. 19 indexed citations
13.
Turner, Elizebeth C. & Charles J. Dorman. (2007). H-NS Antagonism inShigella flexneriby VirB, a Virulence Gene Transcription Regulator That Is Closely Related to Plasmid Partition Factors. Journal of Bacteriology. 189(9). 3403–3413. 52 indexed citations
14.
Turner, Elizebeth C., et al.. (2004). Controlling the DNA Binding Specificity of bHLH Proteins through Intramolecular Interactions. Chemistry & Biology. 11(1). 69–77. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026